REGENOKINE

Welcome to the Brand page for “REGENOKINE”, which is offered here for Medical therapeutic preparations for treatment of joints, muscles, nerves, ligaments, cartilage and bones; dermatological preparations and substances for medical purposes; sanitary preparations for medical purposes;the wording regenokine has no meaning in a foreign language.;medical assistance and hygienic care, in particular in the field of treating diseases of the locomotor system, the nervous system and the immune system; conducting and analysis of dna-based diagnostic tests for rheumatoid diseases and diseases of the locomotor system; medical treatment with cytokine and preparations containing cytokine for treating diseases of the locomotor system and the nervous system;instruments, devices and apparatus for drawing, processing and storage of blood or blood preparations in the medical sector, in particular comprising syringes, blood bags, cannulas;research and development of medicinal products, in particular medical devices and injectable substances; research and development of dna-based diagnostic tests for rheumatoid diseases and diseases of the locomotor system; research and development by cloning and expression of genes; research, development and analysis of the medical effect of substances, including natural substances, on disease relevant parameters for diseases of the locomotor system and the nervous system; research and development with/on cytokine and preparations containing cytokine for treating diseases of the locomotor system and of the nervous system;.

Its status is currently believed to be active. Its class is unavailable. “REGENOKINE” is believed to be currently owned by “Orthogen AG”.